Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.

van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP.

J Alzheimers Dis. 2018;63(2):515-527. doi: 10.3233/JAD-170573. Review.

PMID:
29630548
2.

[7 Tesla MRI for visualisation of small cerebral vessels].

Kloppenborg RP.

Ned Tijdschr Geneeskd. 2017;161:D552. Dutch.

PMID:
28537536
3.

Do Lacunar Infarcts Have Different Aetiologies? Risk Factor Profiles of Lacunar Infarcts in Deep White Matter and Basal Ganglia: The Second Manifestations of ARTerial Disease-Magnetic Resonance Study.

Kloppenborg RP, Nederkoorn PJ, Grool AM, De Cocker LJ, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Cerebrovasc Dis. 2017;43(3-4):161-168. doi: 10.1159/000454782. Epub 2017 Jan 31.

4.

Correction. SMART Study Group. Cerebellar cortical infarct cavities: correlation with risk factors and MRI markers of cerebrovascular disease.

De Cocker LJ, Kloppenborg RP, van der Graaf Y, Luijten PR, Hendrikse J, Geerlings MI.

Stroke. 2016 Feb;47(2):e38. doi: 10.1161/STR.0000000000000094. No abstract available.

PMID:
26811333
5.

Cerebellar Cortical Infarct Cavities: Correlation With Risk Factors and MRI Markers of Cerebrovascular Disease.

De Cocker LJ, Kloppenborg RP, van der Graaf Y, Luijten PR, Hendrikse J, Geerlings MI; SMART Study Group.

Stroke. 2015 Nov;46(11):3154-60. doi: 10.1161/STROKEAHA.115.010093. Epub 2015 Sep 17. Erratum in: Stroke. 2016 Feb;47(2):e38.

PMID:
26382175
6.

Cerebellar infarct patterns: The SMART-Medea study.

De Cocker LJ, Geerlings MI, Hartkamp NS, Grool AM, Mali WP, Van der Graaf Y, Kloppenborg RP, Hendrikse J; SMART study group.

Neuroimage Clin. 2015 Feb 9;8:314-21. doi: 10.1016/j.nicl.2015.02.001. eCollection 2015.

7.

Presence and progression of white matter hyperintensities and cognition: a meta-analysis.

Kloppenborg RP, Nederkoorn PJ, Geerlings MI, van den Berg E.

Neurology. 2014 Jun 10;82(23):2127-38. doi: 10.1212/WNL.0000000000000505. Epub 2014 May 9.

PMID:
24814849
8.

Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study.

Kloppenborg RP, Geerlings MI, Visseren FL, Mali WP, Vermeulen M, van der Graaf Y, Nederkoorn PJ; SMART Study Group.

Neurology. 2014 Mar 4;82(9):777-83. doi: 10.1212/WNL.0000000000000168. Epub 2014 Jan 29.

PMID:
24477110
9.

Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.

Kloppenborg RP, Nederkoorn PJ, Grool AM, Vincken KL, Mali WP, Vermeulen M, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurology. 2012 Nov 13;79(20):2029-36. doi: 10.1212/WNL.0b013e3182749f02. Epub 2012 Oct 31.

PMID:
23115210
10.

Homocysteine, progression of ventricular enlargement, and cognitive decline: the Second Manifestations of ARTerial disease-Magnetic Resonance study.

Jochemsen HM, Kloppenborg RP, de Groot LC, Kampman E, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Alzheimers Dement. 2013 May;9(3):302-9. doi: 10.1016/j.jalz.2011.11.008. Epub 2012 Aug 3.

PMID:
22863909
11.

Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study.

Conijn MM, Kloppenborg RP, Algra A, Mali WP, Kappelle LJ, Vincken KL, van der Graaf Y, Geerlings MI; SMART Study Group.

Stroke. 2011 Nov;42(11):3105-9. doi: 10.1161/STROKEAHA.110.594853. Epub 2011 Aug 25.

PMID:
21868739
12.

[Imaging of small cerebral blood vessels using 7-Tesla MRI].

Kloppenborg RP, Zwanenburg JJ, Luijten PR, Brundel M, Hendrikse J, Nederkoorn PJ.

Ned Tijdschr Geneeskd. 2011;155:A3232. Dutch.

PMID:
21447230
13.

Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study.

Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI.

Atherosclerosis. 2011 Jun;216(2):461-6. doi: 10.1016/j.atherosclerosis.2011.02.027. Epub 2011 Feb 24.

14.

Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment.

Kloppenborg RP, Richard E, Sprengers ME, Troost D, Eikelenboom P, Nederkoorn PJ.

J Neuroinflammation. 2010 Mar 9;7:18. doi: 10.1186/1742-2094-7-18. Review.

15.

Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma.

Kager LM, Kersten MJ, Kloppenborg RP, Van Oers R, Van den Born BJ.

BMJ Case Rep. 2009;2009. pii: bcr06.2009.1926. doi: 10.1136/bcr.06.2009.1926. Epub 2009 Oct 12.

16.

Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition.

van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ.

Biochim Biophys Acta. 2009 May;1792(5):470-81. doi: 10.1016/j.bbadis.2008.09.004. Epub 2008 Sep 23. Review.

17.

Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.

Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ.

Eur J Pharmacol. 2008 May 6;585(1):97-108. doi: 10.1016/j.ejphar.2008.02.049. Epub 2008 Mar 4. Review.

PMID:
18395201
18.

Sclerosing polycystic adenosis: a case report.

Kloppenborg RP, Sepmeijer JW, Sie-Go DM, de Ru JA, Slootweg PJ.

B-ENT. 2006;2(4):189-92.

PMID:
17256407

Supplemental Content

Loading ...
Support Center